Jonas Wang
Director/Miembro de la Junta en TWI BIOTECHNOLOGY, INC. .
Perfil
Jonas Wang is currently the Chairman, President & Chief Executive Officer at StemCyte, Inc. He is also a Director at Epitomics, Inc. and an Independent Director at TWi Biotechnology, Inc. Additionally, he holds the position of Investment Professional at Sycamore Management Corp.
and Sycamore Ventures Pte Ltd.
In the past, Dr. Wang worked as an Associate Director-Basic Pharmaceutics at Bristol Myers Squibb Co., a Director at U-Systems, Inc., and a Vice President-Research & Technology at Johnson & Johnson.
Dr. Wang obtained a graduate degree from the University of Iowa and an undergraduate degree from the National Defense Medical Center.
Cargos activos de Jonas Wang
Empresas | Cargo | Inicio |
---|---|---|
TWI BIOTECHNOLOGY, INC. | Director/Miembro de la Junta | 05/06/2019 |
Sycamore Ventures Pte Ltd.
Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures Pte Ltd. (Sycamore Ventures) is a private equity and venture capital subsidiary of Sycamore Management Corp., founded in 1995 by Mr. Kilin To, Mr. Peter Gerry, and the late Mr. John Whitman. The firm is headquartered in Princeton, New Jersey. | Inversor de Capital Privado | 01/01/2001 |
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Director/Miembro de la Junta | - |
Sycamore Management Corp.
Sycamore Management Corp. Investment ManagersFinance Sycamore Management Corp. (dba Sycamore Ventures) is an independent asset management firm headquartered in Princeton, New Jersey. The firm was founded in 1995 by Joseph Cho and Peter Gerry. Sycamore Ventures manages investment portfolios for individual and institutional clients. | Gestor de Cartera-Acciones | - |
StemCyte, Inc.
StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Presidente | 01/01/2009 |
Antiguos cargos conocidos de Jonas Wang.
Empresas | Cargo | Fin |
---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
U-Systems, Inc.
U-Systems, Inc. Medical SpecialtiesHealth Technology U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY. | Director/Miembro de la Junta | - |
JOHNSON & JOHNSON | Director Técnico/Científico/I+D | - |
Formación de Jonas Wang.
University of Iowa | Graduate Degree |
National Defense Medical Center | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
JOHNSON & JOHNSON | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
TWI BIOTECHNOLOGY, INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Sycamore Ventures Pte Ltd.
Sycamore Ventures Pte Ltd. Investment ManagersFinance Sycamore Ventures Pte Ltd. (Sycamore Ventures) is a private equity and venture capital subsidiary of Sycamore Management Corp., founded in 1995 by Mr. Kilin To, Mr. Peter Gerry, and the late Mr. John Whitman. The firm is headquartered in Princeton, New Jersey. | Finance |
U-Systems, Inc.
U-Systems, Inc. Medical SpecialtiesHealth Technology U-Systems, Inc. designs, develops, manufactures and markets ultrasound systems. The company was founded in 1997 and is headquartered in Schenectady, NY. | Health Technology |
Epitomics, Inc.
Epitomics, Inc. Pharmaceuticals: MajorHealth Technology Epitomics, Inc. an emerging biotechnology company, is dedicated to developing their breakthrough monoclonal antibody technology (RabMAb®) for research, diagnostics and therapeutics. The Company has utilized a unique and proprietary RabMAb technology invented by scientists at Loyola University of Chicago and the University of California at San Francisco. This enabling platform produces high quality antibodies that have the potetial to be used in the broad areas of research, diagnostics and therapeutics. Compared to currently available monoclonal antibody technology, such as mouse hybridomas, the company's proprietary technology can generate RabMAbs more efficiently and with superior binding affinity and bioactivity in a wide variety of biological assays. The high throughput and robust nature of the technology allows for the simultaneous discovery of disease targets and potential therapeutic antibodies in the same experiments, significantly shortening the drug discovery and development cycle. The company aims to become the largest provider of monoclonal antibody technology through developing and commercializing their RabMAb technology and products in research, diagnostics, and therapeutics. The firm is headquartered in Burlingame, California and operates a wholly owned subsidiary in Hangzhou, the People's Republic of China. | Health Technology |
Sycamore Management Corp.
Sycamore Management Corp. Investment ManagersFinance Sycamore Management Corp. (dba Sycamore Ventures) is an independent asset management firm headquartered in Princeton, New Jersey. The firm was founded in 1995 by Joseph Cho and Peter Gerry. Sycamore Ventures manages investment portfolios for individual and institutional clients. | Finance |
StemCyte, Inc.
StemCyte, Inc. BiotechnologyHealth Technology StemCyte, Inc. operates as a biotechnology company that collects, banks and distributes cord blood stem cell transfusion units. It focuses on stem cell transplantation, therapy, applications, diagnostics, and genomic research. The firm uses insulated containers to keep your baby's cord blood cool throughout transport. The company was founded by Denis Rodgerson and Robert Chow in 1997 and is headquartered in Covina, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jonas Wang